Lululemon stock price target lowered to $185 by Morgan Stanley

Morgan Stanley has reduced its price target on Lululemon (LULU) to $185 from $223 while maintaining an Equalweight rating, citing unexpected key performance indicator degradation, a larger-than-anticipated fiscal year guidance reduction, and concerns over a more competitive landscape, delayed Americas recovery, and potential margin erosion from rising inventory and SG&A investments. This follows a 36% stock decline over six months and Q2 revenue missing estimates, prompting similar downgrades from firms like Baird, KeyBanc, BofA, and Rothschild Redburn, suggesting a potential permanent re-rating of LULU's valuation to a lower specialty apparel retail multiple due to persistent growth and margin trajectory challenges.

Analysis

Lululemon Athletica (LULU) is facing a significant negative revision in analyst sentiment, led by Morgan Stanley's price target reduction to $185.00 from $223.00. This bearish consensus is driven by tangible weaknesses observed in the second quarter, including a revenue miss of $15 million and a larger-than-expected reduction in fiscal year guidance. The core issues cited are deteriorating key performance indicators, rising inventory levels, and worse-than-expected markdowns, which threaten the company's historically strong margins. Strategically, management has signaled a delay in the Americas region's recovery until 2026 and a potential slowdown in China, which had previously compensated for weakness elsewhere. This has led multiple firms, including Baird, KeyBanc, and BofA, to issue downgrades or target cuts, reflecting fears of a permanent valuation re-rating. The stock, already down over 36% in six months and trading at a P/E of 12.1, may be transitioning from a high-growth valuation to a lower multiple typical of specialty apparel retailers. While the company maintains strong underlying fundamentals, such as a 59.1% gross profit margin and a 2.27 current ratio, these are being overshadowed by the breakdown in its growth narrative and margin trajectory.

Key Decisions for Investors

• Given the broad-based analyst downgrades and management's own delayed recovery timeline for the Americas, investors should be cautious of further near-term price pressure as a negative revision cycle appears to be underway.
• While the stock's P/E of 12.1 appears low historically, the risk of a permanent valuation re-rating to a specialty retail multiple suggests this could be a value trap, not a clear buying opportunity.
• It is critical to monitor for stabilization in key metrics such as inventory growth, markdown frequency, and revenue trends in the Americas before considering a long position, as these are the primary drivers of the current bearish sentiment.